-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Therapeutic Targeting of STAT3 in MDS and AML Stem Cells

Program: Scientific Workshops @ ASH
Session: Transcription Factors and Epigenetics
Wednesday, December 2, 2020, 8:35 AM-9:15 AM

Aditi Shastri, MD

Department of Hematology and Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Astoria, NY

Disclosures: Shastri: Kymera Therapeutics: Research Funding; GLG: Consultancy; Guidepoint: Consultancy.